SCM
CRMD icon

Sterling Capital Management’s CorMedix CRMD Stock Holding History

Sterling Capital Management’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.8K Buy
1,503
+1,035
+221% +$8.18K ﹤0.01% 2134
2026
Q1 		$3.18K Hold
468
– – ﹤0.01% 2875
2025
Q4 		$5.44K Buy
468
+297
+174% +$3.28K ﹤0.01% 2868
2025
Q3 		$1.99K Buy
171
+16
+10% +$193 ﹤0.01% 2978
2025
Q2 		$1.91K Buy
155
+5
+3% +$55 ﹤0.01% 2929
2025
Q1 		$924 Sell
150
-62
-29% -$642 ﹤0.01% 2842
2024
Q4 		$1.72K Buy
212
+147
+226% +$1.47K ﹤0.01% 2817
2024
Q3 		$525 Buy
+65
New +$352 ﹤0.01% 2849

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Sterling Capital Management's CRMD Position: Q2 2026 in Review

Sterling Capital Management increased its CorMedix (CRMD) stake by 221% in Q2 2026, buying an estimated $8.18K and bringing the position to 1,503 shares worth $11.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2134.

Sterling Capital Management first reported a position in CRMD in Q3 2024 and has held it in 8 quarters since. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Sterling Capital Management held 1,503 shares of CorMedix worth $11.8K as of Q2 2026.
  • Sterling Capital Management bought 1,035 CorMedix shares in Q2 2026, an estimated $8.18K.
  • CorMedix made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2134 holding.
  • Sterling Capital Management first reported a position in CorMedix in Q3 2024 and has held it in 8 quarters since.
  • 194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.